COMP <GO>
GTES vs TMO // EV/EBITDA & P/E VALUATION
Gates Industrial Corporation Ltd. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: GTES 4
— TMO 10
▲ EV/EBITDA & P/E VALUATION LEADER: GTES
LAST: $23.83 (-9.22%) • MKT CAP: $6.65B
valuation
15.2x
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
valuation
30.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GTES VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GTES | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 39.80% | 41.00% | -1.20 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.80% | 9.30% | -1.50 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 15.2x | 30.4x | -15.20 | GTES | /valuation <GO> |
| Free Cash Flow Yield | 6.09% | 2.40% | +3.69 | GTES | /fcf-yield <GO> |
| Operating Margin | 13.50% | 17.40% | -3.90 | TMO | /operating-margins <GO> |
| Net Profit Margin | 7.30% | 15.10% | -7.80 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 1.00% | 3.90% | -2.90 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.46 | 4.50 | -2.04 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 6.70% | +0.20 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 34.8 | 59.1 | -24.32 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | 0.94 | +0.05 | GTES | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.6x | 36.3x | -11.70 | GTES | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.65B | $262.22B | -$255.57B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GTES REV | TMO REV | GTES GROSS % | TMO GROSS % | GTES FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.44B | $44.56B | 39.8% | 44.0% | $404.9M | $6.29B |
| FY 2024 | $3.41B | $42.88B | 39.9% | 44.0% | $296.5M | $7.27B |
| FY 2023 | $3.57B | $42.86B | 44.0% | 44.0% | $320.3M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GTES // BETA 0.99
TMO // BETA 0.94